Enzalutamide With External Beam Radiation for Intermediate Risk Prostate Cancer: A Phase II Study
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 16 Feb 2017
At a glance
- Drugs Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 13 Feb 2017 Status changed from recruiting to active, no longer recruiting.
- 03 Feb 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.